Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 2, 1999, Pages 201-207

  Mitsuyama, Junichi ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; PHENYL GROUP; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TOSUFLOXACIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; COLONY COUNT, MICROBIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032784460     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.2.201     Document Type: Article

References (28)

1. Donowitz, G. R. & Mandell, G. L. (1995). Acute pneumonia. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 619-37. Churchill Livingstone, New York.
2. Espinoza, A. M., Chin, N.-X., Novelli, A. & Neu, H. C. (1988). Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). Antimicrobial Agents and Chemotherapy 32, 663-70.
3. Fujimaki, K., Noumi, T., Saikawa, I., Inoue, M. & Mitsuhashi, S. (1988). In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 32, 827-33.
4. Takahata, M., Otsuki, M. & Nishino, T. (1988). In-vitro and in-vivo activities of T-3262, a new pyridone carboxylic acid. Journal of Antimicrobial Chemotherapy 22, 143-54.
5. Chin, N.-X., Figueredo, V. M., Novelli, A. & Neu, H. C. (1988). In vitro activity of temafloxacin, a new difluoroquinolone antimicrobial agent. European Journal of Clinical Microbiology and Infectious Diseases 7, 58-63.
6. Hardy, D. J., Swanson, R. N., Hensey, D. M., Ramer, N. R., Bower, R. R., Hanson, C. W. et al. (1987). Comparative antibacterial activities of temafloxacin hydrochioride (A-62254) and two reference fluoroquinolones. Antimicrobial Agents and Chemotherapy 31, 1768-74.
7. Chin, N.-X., Gu, J.-W., Yu, K.-W., Zhang, Y.-X. & Ne, H. C. (1991). In vitro activity of sparfloxacin. Antimicrobial Agents and Chemotherapy 35, 567-71.
8. Cooper, M. A., Andrews, J. M., Ashby, J. P., Matthews, R. S. & Wise, R. (1990). In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy 26, 667-76.
9. Lewin, C. S., Morrissey, I. & Smith, J. T. (1991). The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment. European Journal of Clinical Microbiology and Infectious Diseases 10, 240-8.
10. Azoulay-Dupuis, E., Bedos. J. P., Vallee, E., Hard, D. J., Swanson, R. N. & Pocidalo, J. J. (1991). Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease. Journal of Infectious Diseases 163, 319-24.
11. Azoulay-Dupuis, E., Bedos, J. P., Vallee, E. & Pocidalo, J. J. (1991 ). Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. Journal of Antimicrobial Chemotherapy 28, Suppl. C, 45-53.
12. Azoulay-Dupuis, E., Vallee, E., Veber, B., Bedos, J. P., Bauchet, J. & Pocidalo, J. J. (1992). In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrobial Agents and Chemotherapy 36, 2698-703.
13. Hardy, D. J. (1991). Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens. American Journal of Medicine 91, Suppl. 6A, 12S-14S.
14. Imada, T., Miyazaki, S., Nishida, M., Yamaguchi, K. & Goto, S. (1992). In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116. Antimicrobial Agents and Chemotherapy 36, 573-9.
15. Iwasaki, H., Miyazaki, S., Tsuji, A., Yamaguchi, K. & Goto, S. (1995). In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone. Chemotherapy 41, 100-12.
16. Bustamante, C. I., Drusano, G. L., Tatem, B. A. & Standiford, H. C. (1984). Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 26, 678-82.
17. Craig, W. A. & Gudmundsson, S. (1986). The postantibiotic effect. In Antibiotics in Laboratory Medicine, 2nd edn (Lorian, V., Ed.), pp. 515-36. Williams & Wilkins, Baltimore, MD.
18. Minami, R., Nakamura, C., Inotsume, N. & Nakano, M. (1998). Effects of alminium hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers. Antimicrobial Agents and Chemotherapy 42, 453-5.
19. Miyazaki, S., Domon, H., Tateda, K., Ohno, A., Ishii, Y., Matsumoto, T. et al. (1997). In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections. Antimicrobial Agents and Chemotherapy 41, 2582-5.
20. Girard, A. E., Girard, D., Gootz, T. D., Faiella, J. A. & Cimochowski, C. R. (1995). In vitro efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against Gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis, Antimicrobial Agents and Chemotherapy 39, 2210-6.
21. Visalli, M. A., Jacobs, M. R. & Applebaum, P. C. (1996). Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, Iomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology. Journal of Antimicrobial Chemotherapy 37, 77-84.
22. Walters, R. N., Piddock, L. J. V. & Wise, R. (1989). The effect of mutations in the SOS response on the kinetics of quinolone killing. Journal of Antimicrobial Chemotherapy 24, 863-73.
23. Crumplin, G. C. & Smith, J. T. (1975). Nalidixic acid: an antibacterial paradox. Antimicrobial Agents and Chemotherapy 8, 251-61.
24. Piddock, L. V., Walters, R. N. & Diver, J. M. (1990). Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli. Antimicrobial Agents and Chemotherapy 34, 2331-6.
25. Smith, J. T. (1986). The mode of action of 4-quinolones and possible mechanisms of resistance. Journal of Antimicrobial Chemotherapy 18, Suppl. D, 21-9.
26. Stevens, P. J. E. (1980). Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds. Journal of Antimicrobial Chemotherapy 6, 535-42.
27. Fuursted, K. (1987). Post-antibiotic effect of ciprofloxacin on Pseudomonas aeruginosa. European Journal of Clinical Microbiology 6, 271-4.
28. Gottfredsson, M., Erlendsdottir, H., Gudmundsson, A. & Gudmundsson, S. (1995). Different patterns of bacterial DNA synthesis during postantibiotic effect. Antimicrobial Agents and Chemotherapy 39, 1314-9.